In last trading session, Akero Therapeutics Inc (NASDAQ:AKRO) saw 1.26 million shares changing hands with its beta currently measuring -0.16. Company’s recent per share price
Akero Therapeutics Inc (NASDAQ:AKRO) has a beta value of -0.18 and has seen 2.94 million shares traded in the last trading session. The company, currently
In today’s recent session, 0.56 million shares of the Akero Therapeutics Inc (NASDAQ:AKRO) have been traded, and its beta is -0.19. Most recently the company’s
In the last trading session, 6.81 million Akero Therapeutics Inc (NASDAQ:AKRO) shares changed hands as the company’s beta touched -0.27. With the company’s per share
In last trading session, Akero Therapeutics Inc (NASDAQ:AKRO) saw 1.42 million shares changing hands with its beta currently measuring -0.26. Company’s recent per share price
Akero Therapeutics Inc (NASDAQ:AKRO) has a beta value of -0.19 and has seen 2.2 million shares traded in the last trading session. The company, currently
Akero Therapeutics Inc (NASDAQ:AKRO)’s traded shares stood at 1.42 million during the last session, with the company’s beta value hitting -0.13. At the close of
In the last trading session, 1.41 million Akero Therapeutics Inc (NASDAQ:AKRO) shares changed hands as the company’s beta touched -0.11. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne